TickerFactsScreenerDevelopers

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $57.34M2008: $183.55M2009: $71.89M2010: $128.76M2011: $100.81M2012: $96.94M2013: $120.61M2014: $71.73M2015: $48.13M2016: $102.06M2017: $174.94M2018: $138.84M2019: $198.91M2020: $470.17M2021: $513.45M2022: $456.66M2023: $276.40M2024: $246.38M2025: $235.05M$235.05M
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$235.05M-4.6%
2024$246.38M-10.9%
2023$276.40M-39.5%
2022$456.66M-11.1%
2021$513.45M+9.2%
2020$470.17M+136.4%
2019$198.91M+43.3%
2018$138.84M-20.6%
2017$174.94M+71.4%
2016$102.06M+112.0%
2015$48.13M-32.9%
2014$71.73M-40.5%
2013$120.61M+24.4%
2012$96.94M-3.8%
2011$100.81M-21.7%
2010$128.76M+79.1%
2009$71.89M-60.8%
2008$183.55M+220.1%
2007$57.34M—